During the past decade, Marco Confalonieri conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marco Confalonieri" #1 collaborator was "Centro di Riferimento Oncologico - Aviano" with 1 trials as a collaborator and "National Institute for the Infectious Diseases (L. Spallanzani) - Rome" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Marco Confalonieri" are "ARDS, Human" (1 trials), "Coronavirus Infections" (1 trials), "Covid19" (1 trials), "Severe Acute Respiratory Syndrome" (1 trials) and "Severe Acute Respiratory Syndrome (SARS) Pneumonia" (1 trials). Many other conditions were trialed in "Marco Confalonieri" in a lesser frequency.

Most popular intervention types in "Marco Confalonieri" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Methylprednisolone" (2 trials), "Dexamethasone" (1 trials) and "standard care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marco Confalonieri" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Marco Confalonieri". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Marco Confalonieri, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marco Confalonieri, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".